PL.02: Plenary lecture
|
| |
 |
PL.02.01: René S. Kahn - The Netherlands |
Structural brain changes in schizophrenia: what we have learned over the last 20 years |
E.03: Educational update session: Diagnosis and treatment of tic disorders
|
 |
|
E.03.01: Danielle C. Cath - The Netherlands |
Differential diagnosis of jerky movement disorders |
S.05: Symposium: Schizoaffective disorder: construct and treatment
|
| |
|
S.05.01: Jim Van Os - The Netherlands |
A revolution which did not occur: schizoaffective disorder in DSM-5 |
| |
|
S.05.02: Andrea Murru - Spain |
Meeting the unmet needs in the treatment of schizoaffective disorder |
| |
|
S.05.03: Alessandra Nivoli - Spain |
Switching antipsychotics in schizoaffective disorder: rules and cautions |
| |
|
S.05.04: Heinz Grunze - United Kingdom |
Differentiating schizoaffective and bipolar disorder: a dimensional approach |
S.06: Symposium: Neurobiology of ADHD across the lifespan
|
| |
|
S.06.01: Bru Cormand - Spain |
The genetics of ADHD across the lifespan: tales and reality of common and rare genetic variants |
| |
|
S.06.02: Jan K. Buitelaar - The Netherlands |
Effects of psychotropic drugs in the ADHD brain |
| |
|
S.06.03: Klaus-Peter Lesch - Germany |
Translating genetic findings into biological mechanisms for ADHD through animal models |
S.07: Symposium: Junior Scientists symposium – New insights into the pathophysiological substrates underlying psychiatric disorders
|
| |
|
S.07.01: Dienke J. Bos - The Netherlands |
Developmental differences in higher-order resting-state networks in autism spectrum disorder |
| |
|
S.07.02: Lizanne Schweren - The Netherlands |
Structural brain correlates of atypical antipsychotic augmentation to methylphenidate treatment in adolescents with ADHD |
| |
|
S.07.03: Joanna Slusarczyk - Poland |
Prenatal stress influences the neuron-glia interaction – a link to depression |
| |
|
S.07.04: Katrin Preller - Switzerland |
Social interaction in cocaine users: altered response to joint attention and underlying functional changes of the reward system |
| |
|
S.07.05: Scott Mitchell - United Kingdom |
The effects of early life stress on nucleus accumbens GABAA receptor function and cocaine mediated behaviour |
| |
|
S.07.06: Alexandre Surget - United Kingdom |
Antidepressant treatment enhances the capacity for disambiguation in the hippocampus |
| |
|
S.07.07: Vincent Marzloff - France |
The social cognition network and its impairment in schizophrenia: medial prefrontal cortex functional deficit in an emotional task |
| |
|
S.07.08: Benedetta Vai - Italy |
Disrupted effective connectivity of emotional circuitry in schizophrenia: a dynamic causal modeling study |
S.08: Symposium: Cocaine and glutamatergic plasticity
|
| |
|
S.08.04: Wim Van den Brink - The Netherlands
|
Imaging glutamate homeostatis in cocaine addiction
|
S.09: Symposium: TNM symposium – Compulsivity – transdiagnostic perspective: new models, disorders and treatments
|
| |
|
S.09.01: Eric Hollander, M.D. - USA |
The cost and impact of compulsivity |
| |
|
S.09.02: Anna E. Goudriaan - The Netherlands |
Modelling compulsivity: from animals to human endophenotypes |
| |
|
S.09.03: Dick J. Veltman - The Netherlands |
Imaging compulsivity: from the group to the individual |
S.10: Symposium: Type 2 diabetes and Alzheimer's
|
| |
|
S.10.03: Geert-Jan Biessels - The Netherlands |
Functional and structural neuroimaging in type 2 diabetes |
| |
|
S.10.04: Deborah Gustafson - USA |
Obesity, brain functioning and Alzheimer's disease |
S.11: Symposium: Recent advances in developmental disorders
|
| |
|
S.11.01: Christian Marshall - Canada |
Recent advances in the genetics of autism spectrum disorder |
| |
|
S.11.03: Maarten Titulaer - The Netherlands |
NMDA receptor encephalitis or schizophrenia? |
CD.01: Career development session:
How to combine your clinical work, science and personal life |
| |
 |
Gitte Moos Knudsen - Denmark |
|
| |
|
Gil Zalsman - Israel |
|
